Plcxd1, a phospholipase-C-like gene, may be involved in multiple biological processes. Although its exact function is not fully elaborated, its association with certain pathways and disease-related processes is emerging. It has been suggested to be part of the genetic regulation network, potentially related to chromatin modification-associated processes as it was found among genes down-regulated in adult mutant mice with Mll2 haplo-insufficiency, a histone methyltransferase gene linked to glucose homeostasis and type 2 diabetes [1].

In a study on malignant melanoma, PLCXD1 was identified as one of the genes in areas of deletion. It demonstrated diminished expression in primary melanomas relative to benign nevi and was significantly increased in expression by 5-Aza treatment, showing growth-suppressive properties when transfected into melanoma-derived cell lines, indicating its potential role as a tumor-suppressor gene in melanoma [2]. Also, in bladder cancer EJ cells, PLCXD1 was identified as a candidate molecular target of Diallyl trisulfide (DATS), a compound with anti-carcinogenic activity [3].

In conclusion, Plcxd1 seems to play roles in processes related to disease development such as in type 2 diabetes-associated genetic regulation, melanoma tumor-suppression, and as a potential target in bladder cancer treatment. These findings from different disease-based studies using various experimental models help to gradually clarify the biological functions of Plcxd1 and its significance in disease-related pathways.

References:

1. Goldsworthy, Michelle, Absalom, Nathan L, Schröter, David, Hollfelder, Florian, Cox, Roger D. 2013. Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice. In PloS one, 8, e61870. doi:10.1371/journal.pone.0061870. https://pubmed.ncbi.nlm.nih.gov/23826075/

2. Mithani, Suhail K, Smith, Ian M, Califano, Joseph A. . Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma. In Melanoma research, 21, 298-307. doi:10.1097/CMR.0b013e328344a003. https://pubmed.ncbi.nlm.nih.gov/21606880/

3. Shin, Seung-Shick, Song, Jun-Hui, Hwang, Byungdoo, Kim, Wun-Jae, Moon, Sung-Kwon. 2017. Angiopoietin-like protein 4 potentiates DATS-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; involvement of G2/M-phase cell cycle arrest, signaling pathways, and transcription factors-mediated MMP-9 expression. In Food & nutrition research, 61, 1338918. doi:10.1080/16546628.2017.1338918. https://pubmed.ncbi.nlm.nih.gov/28680385/